Impact of antidepressants on the risk of suicide in patients with depression in real-life conditions: a decision analysis model

被引:19
|
作者
Cougnard, A. [1 ]
Verdoux, H. [1 ]
Grolleau, A. [1 ]
Moride, Y. [2 ]
Begaud, B. [1 ]
Tournier, M. [1 ]
机构
[1] Univ Victor Segalen Bordeaux 2, INSERM, U657, IFR Publ Hlth, Bordeaux, France
[2] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
关键词
Antidepressant; decision analysis; depression; suicide; SEROTONIN REUPTAKE INHIBITORS; PSYCHIATRIC-DISORDER; MORTALITY; PREVALENCE; CHILDREN; THERAPY; TRIALS; ADULTS; PRIMER;
D O I
10.1017/S003329170800473X
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. The impact of antidepressant drug treatment (ADT) on the risk of suicide is uncertain. The aim of this study was to determine in a real-life setting whether ADT is associated with an increased or a reduced risk of suicide compared to absence of ADT (no-ADT) in patients with depression. Method. A decision analysis method was used to estimate the number of suicides prevented or induced by ADT in children and adolescents (10-19 years old), adults (20-64 years old) and the elderly (>= 65 years) diagnosed with major depression. The impact of gender and parasuicide history on the findings was explored within each age group. Sensitivity analyses were used to assess the robustness of the models. Results. Prescribing ADT to all patients diagnosed with depression would prevent more than one out of three suicide deaths compared to the no-ADT strategy, irrespective of age, gender or parasuicide history. Sensitivity analyses showed that persistence in taking ADT would be the main characteristic influencing the effectiveness of ADT on suicide risk. Conclusions. Public health decisions that contribute directly or indirectly to reducing the number of patients with depression who are effectively administered ADT may paradoxically induce a rise in the number of suicides.
引用
收藏
页码:1307 / 1315
页数:9
相关论文
共 50 条
  • [41] Impact of Omalizumab on Food Allergy in Patients Treated for Asthma: A Real-Life Study
    Fiocchi, Alessandro
    Artesani, Maria Cristina
    Riccardi, Carla
    Mennini, Maurizio
    Pecora, Valentina
    Fierro, Vincenzo
    Calandrelli, Veronica
    Dahdah, Lamia
    Valluzzi, Rocco Luigi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (06): : 1901 - +
  • [42] REAL-LIFE IMPACT OF THE POD24 INDICATOR IN PATIENTS WITH FOLLICULAR LYMPHOMA
    Noguerales Blanca, De Felipe
    de Abia Alejandro, Luna
    Arribas Ana, Lario
    Rumschisky Pablo, Palomo
    Jarreta Lucia, Bolea
    Palomares Juan, Marquet
    Moro Fernando, Martin
    Cosio Monica, Garcia
    Puente Pilar, Herrera
    Francisco Javier, Lopez Jimenez
    HAEMATOLOGICA, 2021, 106 (10) : 49 - 49
  • [43] Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Rheumatic Conditions: A Qualitative Analysis of Perceived Risk and Decision Making
    Wells, Courtney
    Torres, Guadalupe
    Nowell, William
    Venkatachalam, Shilpa
    Stradford, Laura
    Gavigan, Kelly
    Boyd-Floering, Barbara
    Danila, Maria I.
    Carandang, Kristine
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3336 - 3337
  • [44] Ischaemic and haemorrhagic risk distribution in real-life patients with acute coronary syndromes
    Weckesser, Federico
    Rivero, Mirza
    Conde, Diego
    Perez, Gonzalo
    Zaidel, Ezequiel
    Garmendia, Cristian
    Sabouret, Pierre
    Trivi, Marcelo
    Costabel, Juan Pablo
    ACTA CARDIOLOGICA, 2024, 79 (05) : 530 - 535
  • [45] Evaluation of Thromboembolism Risk in Patients with Cancer; Single Center Real-life Data
    Erdem, Simge
    Gursu, Riza Umar
    Erguney, Mecdi Hikmet
    Ar, Muhlis Cem
    ISTANBUL MEDICAL JOURNAL, 2023, 24 (02): : 204 - 209
  • [46] EFFECTIVENESS OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: A REAL-LIFE ANALYSIS
    Picciariello, L.
    Ceccarelli, F.
    Natalucci, F.
    Olivieri, G.
    Pirone, C.
    Orefice, V.
    Garufi, C.
    Spinelli, F. R.
    Priori, R.
    Alessandri, C.
    Conti, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1346 - 1346
  • [47] REAL-LIFE SURVIVAL ANALYSIS OF A COHORT OF POLYCYTHEMIA VERA PATIENTS OF A CENTER
    Juan Francisco, Lopez Rodriguez
    Acosta Eva, Perez
    Diaz Adrian, Segura
    Sieyro Cristina, Bilbao
    Ruth, Stuckey
    Sosa Santiago, Sanchez
    Ortega Yanira, Florido
    Santana Guillermo, Santana
    Borrego Asuncion, Borrero
    Gonzalez Paula, Fernandez-Caldas
    Melian Haridian, De la Nuez
    Curbelo Alejandro, Morales
    De la Cruz Marcos, Cabezas
    Rodriguez Patricia, Arenas
    Bullon Laura, Navarrete
    Maria Teresa, Gomez Casares
    HAEMATOLOGICA, 2021, 106 (10) : 256 - 257
  • [48] Analysis of Patients Undergoing Metronidazole Challenge Testing: Real-Life Data
    Telli, Onur
    Aksu, Kurtulus
    Akkale, Ozgur
    Celik Tuglu, Hatice
    Yagdiran, Melis
    Dindar Celik, Fatma
    Vural Solak, Gurgun Tugce
    ASTHMA ALLERGY IMMUNOLOGY, 2025,
  • [49] Cases of real-life policies related to risk: How can they enhance risk analysis and risk science?
    Aven, Terje
    RISK ANALYSIS, 2023, 43 (03) : 433 - 439
  • [50] Evaluation of rofecoxib in patients with osteoarthritis under real-life conditions - The valor study in Colombia
    Forero, JH
    Alfonso, R
    Arabelaez, F
    Hunsche, E
    Kong, SX
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 540 - 540